Gujarat Terce Laboratories Complete Financial Statements

11 Years of Data
2025 - 2015

In FY2021, Gujarat Terce Laboratories (GUJTERC) reported revenue ₹10 Cr, net profit ₹0 Cr and EPS ₹0.61. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review Gujarat Terce Laboratories price earnings to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

EBITDA Margin 10.00% 2021 data
Operating Margin 5.00% 2021 data

Balance Sheet Ratios

Current Ratio 3.00 2021 data
Equity Ratio 30.43% 2021 data
Asset Turnover 0.43 2021 data

GUJTERC Revenue, Net Profit & EBITDA — Year-on-Year Growth

GUJTERC YoY (Sept 2020 vs Sept 2021) — revenue +42.9%, expenses +42.9%. For live price, earnings ratios and company overview, see GUJTERC screener.

Revenue Growth
+42.9%
Year-over-Year
Expense Growth
+42.9%
Year-over-Year
Investing Cash Flow Growth
+200.0%
Year-over-Year
Financing Cash Flow Growth
+25.0%
Year-over-Year

GUJTERC Income Statement — Revenue, EBITDA & Net Profit

Gujarat Terce Laboratories revenue ₹10 Cr, EBITDA ₹1 Cr, net profit ₹0 Cr, EPS ₹0.61 (2021). Explore GUJTERC true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2021 Jun 2021 Sept 2020 Mar 2020 Jun 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Dec 2018
Revenue 10 10 7 10 5 11 8 7 10 8
Expenses 10 8 7 10 5 9 8 8 10 8
EBITDA 1 2 0 0 0 2 0 -1 1 1
Operating Profit Margin % 5.00% 16.00% 2.00% -5.00% -8.00% 17.00% 2.00% -16.00% 4.00% 8.00%
Depreciation 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 2 0 0 0 2 0 -1 0 1
Tax 0 0 0 0 0 0 0 0 0 0
Net Profit 0 2 0 -1 0 2 0 -1 0 1
Earnings Per Share (₹) 0.61 2.16 -0.02 0.00 -0.60 2.28 0.49 0.00 0.50 0.77

GUJTERC Balance Sheet — Assets, Liabilities & Shareholders' Equity

GUJTERC total assets ₹23 Cr, total equity ₹7 Cr, total liabilities ₹ Cr (2025).

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 23 23 29 27 22 23 19 20 24 25 26
Current Assets 12 11 16 16 12 12 9 10 13 15 17
Fixed Assets 4 4 4 4 3 2 2 2 6 6 7
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 1 0 0 0 0 0 0 0 0 0 0
Other Assets 19 19 24 23 19 20 17 17 17 18 20
LIABILITIES
Total Liabilities
Current Liabilities 4 4 5 6 3 2 2 2 8 8 8
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 7 7 7 9 8 11 11 10 10 10 11
Share Capital 7 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus -1 0 -1 1 0 4 3 3 3 3 4

GUJTERC Cash Flow Statement — Operating, Investing & Financing

Gujarat Terce Laboratories operating cash flow ₹3 Cr, investing ₹1 Cr, financing ₹-3 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 3 3 0 0 0 -2 -1 5 0 0 1
Investing Activities 1 -1 1 -1 0 0 0 1 0 0 0
Financing Activities -3 -4 0 2 2 2 0 -5 0 -1 -1
Net Cash Flow 1 -2 1 0 1 0 -1 0 0 -1 1